SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001193125-19-316287
Filing Date
2019-12-17
Accepted
2019-12-17 16:38:56
Documents
2
Period of Report
2019-08-08
Items
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K/A d850951d8ka.htm 8-K/A 20087
2 EX-23.1 d850951dex231.htm EX-23.1 2222
  Complete submission text file 0001193125-19-316287.txt   23585
Mailing Address SUITE 360 - 1616 EASTLAKE AVE EAST SEATTLE WA 98102
Business Address SUITE 360 - 1616 EASTLAKE AVE EAST SEATTLE WA 98102 206-732-2133
Neoleukin Therapeutics, Inc. (Filer) CIK: 0001404644 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 001-36327 | Film No.: 191290223
SIC: 2834 Pharmaceutical Preparations